News

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Ticker TV interviews CEO Andreas Fouras on commercial evaluation with I-MED Radiology Network and next stage of real-world application of XV Technology [3:47] Learn more here: I-MED phase two clinical program[/vc_column_text][/vc_column][/vc_row]...

MEDIA RELEASE 19 August 2021 4DMedical partnering with Lung Foundation Australia to prepare for a post-COVID nation Medical imaging innovator 4DMedical is teaming with Lung Foundation Australia to protect the health and wellbeing of people impacted by the residual physiological effects of the COVID-19 pandemic. Over 33,000 Australians...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]Dr Andreas Fouras on B2B commercial prospects:  Interview with Nadine Blayney on 'The Open' 11AUG2021 [viewing time 3:32] Learn more about our pharma solutions: https://4dmedical.com/pharma-solutions/[/vc_column_text][/vc_column][/vc_row]...

MEDIA RELEASE 5 August 2021 Respiratory imaging disruptor 4DMedical announces further application of its XV LVAS (Lung Ventilation Analysis Software) technology, through its use in validating interventional pulmonary treatments in a range of clinical activities in the United States. The interventional pulmonology market valued at US$1.3 billion...

Further validation of XV Technology application to COPD conditions, with results communicated to the global clinical and medical research communities by respected Johns Hopkins experts. [video width="1920" height="1080" mp4="https://4dmedical.com/wp-content/uploads/2021/07/Andreas-Fouras-on-Johns-Hopkins-Clinical-Trials-09-July-2021.mp4"][/video]...

US advocacy organisation, the Physician-Patient Alliance for Health & Safety (PPAHS) has published a Position Paper recognising the need for improved technologies and procedures to measure lung dynamics and function during pandemics. [pdf-embedder url="https://4dmedical.com/wp-content/uploads/2021/07/4DMedical-MEDIA-RELEASE-_-PPAHS-White-Paper-07JUL2021.pdf" title="4DMedical MEDIA RELEASE _ PPAHS White Paper 07JUL2021"]...

A second clinical trial validating the clinical application of 4DMedical’s XV Technology has commenced at Johns Hopkins University in Baltimore, one the world’s most renowned centres of research translation. [pdf-embedder url="https://4dmedical.com/wp-content/uploads/2021/06/MEDIA-RELEASE-_-4DMedical-Johns-Hopkins-29JUN2021.pdf" title="MEDIA RELEASE _ 4DMedical Johns Hopkins 29JUN2021"]   Read more about our comprehensive program of clinical trials.  ...